Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 243070467 approvals141 trials

HUONS CO., LTD.

Official website

KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Established in 2016 and listed on KOSDAQ in 2016, Huons is a pharmaceutical and healthcare company. It manufactures lidocaine local anesthetics, the Kynix hyaluronic-acid eye drop line, and the Merit series of high-dose vitamin injections and health functional foods, spanning prescription drugs, beauty/wellness, and CMO contract manufacturing. Through its Jecheon plant (built 2009) and second plant (completed 2022, GMP-certified August 2023), it exports lidocaine and other injectables under US FDA ANDA approvals, and expanded into biosimilars and CDMO by acquiring a stake in Pangen in December 2024, which became a subsidiary in June 2025.

Products & technology

  • Lidocaine local anestheticLocal anesthesia
  • Kynix (hyaluronic acid eye drop)Ophthalmic eye-drop treatment
  • Merit series (high-dose vitamin injections and health functional foods)Beauty and wellness

Regulatory approvals

data.go.kr

461 Korean MFDS drug approvals · 1970–2026 / 6 Korean MFDS device approvals · 2011–2020

  • MFDS drugHutava ODT 2mg(Pitavasatin Calcium Hydrate)2026-07-30
    Drug · Prescription · Approval202602220
  • MFDS drugHutava ODT 4mg(Pitavastatin Calcium Hydrate)2026-07-30
    Drug · Prescription · Approval202602221
  • MFDS drugHuons Dexketoprofen Inj. (Dexketoprofen trometamol)2026-07-27
    Drug · Prescription · Approval202602157
  • MFDS drugLUMIEJU PDRN CREAM(Polydeoxyribonucleotide Sodium)2026-06-29
    Drug · OTC · Notification202601831
  • MFDS drugBesylsartan Q Tab. 5/100/5mg(Amlodipine besylate, losartan potassium, rosuvastatin calcium)2026-06-15
    Drug · Prescription · Approval202601697
  • MFDS drugHupran Tab. 50mg(Pranlukast hydrate)2026-05-22
    Drug · Prescription · Approval202601490
  • MFDS drugHunoxidil Tab. 5mg (Minoxidil)2026-02-26
    Drug · Prescription · Approval202600590
  • MFDS drugPrega ODT 75mg2026-02-24
    Drug · Prescription · Approval202600536
  • MFDS drugPrega ODT 50mg2026-02-24
    Drug · Prescription · Approval202600537
  • MFDS drugPrega ODT 150mg2026-02-24
    Drug · Prescription · Approval202600538
  • MFDS drugRocatan Tab. 25mg (Losartan potassium)2025-12-24
    Drug · Prescription · Approval202503377
  • MFDS drugLidocaine HCl Injection 2%2025-12-23
    Drug · Prescription · Approval202503365
Show 68 more
  • MFDS drugMucoramin SR Tablet 150mg (Rebamipide)2025-12-09
    Drug · Prescription · Approval202503222
  • MFDS drugMigslim Tab. 50mg (Miglitol)2025-12-08
    Drug · Prescription · Approval202503191
  • MFDS drugHUAMINA Tab.2025-11-28
    Drug · OTC · Notification202503122
  • MFDS drugSacchalus-duo Cap.2025-10-13
    Drug · OTC · Notification202502638
  • MFDS drugHUBACTAM Inj. 2.25g (Piperacillin SodiumTazobactam Sodium)2025-10-02
    Drug · Prescription · Approval202502624
  • MFDS drugBesylsartan Q Tab. 5/100/10mg(Amlodipine besylate, losartan potassium, rosuvastatin calcium)2025-09-19
    Drug · Prescription · Approval202502493
  • MFDS drugBesylsartan Q Tab. 5/50/10mg(Amlodipine besylate, losartan potassium, rosuvastatin calcium)2025-09-19
    Drug · Prescription · Approval202502494
  • MFDS drugMerit G Inj. (N(2)-L-alanyl-L-glutamine)2025-09-09
    Drug · Prescription · Approval202502388
  • MFDS drugNizoral 1% Sol. (Ketoconazole)2025-08-13
    Drug · OTC · Approval202502089
  • MFDS drugLIVAFENON Cap. 2/160mg (Pitavastatin calcium,Fenofibrate)2025-07-11
    Drug · Prescription · Approval202501757
  • MFDS drugHuperaflu Inj.2025-07-09
    Drug · Prescription · Approval202501732
  • MFDS drugHurotadine Eye Drops 0.7% (Olopatadine hydrochloride)2025-07-09
    Drug · Prescription · Approval202501734
  • MFDS drugHUDIANCE Duo XR Tab. 5/1000mg (Empagliflozin,Metformin)2025-07-01
    Drug · Prescription · Approval202501631
  • MFDS drugHUDIANCE Duo XR Tab. 12.5/1000mg (Empagliflozin,Metformin)2025-07-01
    Drug · Prescription · Approval202501632
  • MFDS drugHUDIANCE Duo XR Tab. 10/1000mg (Empagliflozin,Metformin)2025-06-23
    Drug · Prescription · Approval202501552
  • MFDS drugHUDIANCE Duo XR Tab. 25/1000mg (Empagliflozin,Metformin)2025-06-23
    Drug · Prescription · Approval202501553
  • MFDS drugHurapang tab.2025-06-20
    Drug · Prescription · Approval202501528
  • MFDS drugDreamel PR tab. 2mg (Melatonin)2025-04-22
    Drug · Prescription · Approval202500950
  • MFDS drugHUSIGLOM SR Tab. 5/50/1000mg2025-03-27
    Drug · Prescription · Approval202500711
  • MFDS drugCal-D-Up BD Tab.2025-03-27
    Drug · OTC · Notification202500721
  • MFDS drugHurotadine Eye Drops 0.2% (Olopatadine hydrochloride)(single-dose), Hurotadine Eye Drops 0.2% (Olopatadine hydrochloride)2025-01-13
    Drug · Prescription · Approval202500100
  • MFDS drugHUSIGLOM SR Tab. 10/100/1000mg2025-01-08
    Drug · Prescription · Approval202500060
  • MFDS drugSatie SR Tab. 25mg (Topiramate)2024-12-16
    Drug · Prescription · Approval202402973
  • MFDS drugSatie SR Tab. 50mg (Topiramate)2024-11-29
    Drug · Prescription · Approval202402828
  • MFDS drugHu-liem Tab. 10/5mg2024-10-21
    Drug · Prescription · Approval202402465
  • MFDS drugHu-liem Tab. 25/5mg2024-10-21
    Drug · Prescription · Approval202402466
  • MFDS drugHusetan Tab(Sevelamer carbonate)2024-10-15
    Drug · Prescription · Approval202402436
  • MFDS drugAmiceta Powder 500mg(Acetaminophen)2024-10-02
    Drug · OTC · Notification202402363
  • MFDS drugAsrabe Cap.100/5mg(Aspirin,Rabeprazole)2024-09-30
    Drug · Prescription · Approval202402347
  • MFDS drugCergol Tab. 10mg (Nicergoline)2024-09-26
    Drug · Prescription · Approval202402318
  • MFDS drugEfirush topical solution (Efinaconazole)2024-04-29
    Drug · Prescription · Approval202401007
  • MFDS drugGinkgobal Tab. 240mg (Ginkgo leaf drided extract)2024-04-24
    Drug · OTC · Notification202400966
  • MFDS drugHuons Isoproterenol Hydrochloride Inj.2024-04-16
    Drug · Prescription · Approval202400863
  • MFDS drugLinaD4 Duo XR Tab. 5/1000mg (Linagliptin, Metformin)2024-03-18
    Drug · Prescription · Approval202400567
  • MFDS drugLinaD4 Duo XR Tab. 2.5/1000mg (Linagliptin, Metformin)2024-03-18
    Drug · Prescription · Approval202400569
  • MFDS drugCergol Tab. 30mg (Nicergoline)2024-02-28
    Drug · Prescription · Approval202400418
  • MFDS drugAperin Plus B Tab.2024-02-21
    Drug · OTC · Notification202400374
  • MFDS drugAperin Plus BC Tab.2024-02-21
    Drug · OTC · Notification202400375
  • MFDS drugNiotin Tab.2023-12-20
    Drug · OTC · Notification202303390
  • MFDS drugHuvnac Eye drops (Bromfenac sodium hydrate)2023-10-30
    Drug · Prescription · Approval202303028
  • MFDS drugEasymantine Tab. 20mg (Memantine hydrochloride)2023-10-26
    Drug · Prescription · Approval202302992
  • MFDS drugLevomon Tab.(Montelukast Sodium, Levocetirizine Hydrochloride)2023-08-30
    Drug · Prescription · Approval202302551
  • MFDS drugHusiglo Tab. (Dapagliflozin,Sitagliptin)2023-06-29
    Drug · Prescription · Approval202302005
  • MFDS drugHuglia M Tablet 50/500 mg2023-03-13
    Drug · Prescription · Approval202300848
  • MFDS drugHuglia M Tablet 50/850 mg2023-03-13
    Drug · Prescription · Approval202300849
  • MFDS drugHuglia M Tablet 50/1000 mg2023-03-13
    Drug · Prescription · Approval202300850
  • MFDS drugMOISTA CMC EYE DROPS 1.0%2023-03-08
    Drug · OTC · Notification202300801
  • MFDS drugHuglia M XR Tablet 50/500 mg2023-02-17
    Drug · Prescription · Approval202300602
  • MFDS drugHuglia M XR Tablet 50/1000 mg2023-02-17
    Drug · Prescription · Approval202300603
  • MFDS drugHuglia M XR Tablet 100/1000 mg2023-02-17
    Drug · Prescription · Approval202300604
  • MFDS drugHuxiga Tab. 10mg(Dapagliflozin propanediol hydrate)2023-01-30
    Drug · Prescription · Approval202300390
  • MFDS drugHuxigaduo XR Tab. 10/500mg(Dapagliflozin, Metformin)2023-01-27
    Drug · Prescription · Approval202300359
  • MFDS drugHuxigaduo XR Tab. 10/1000mg(Dapagliflozin, Metformin)2023-01-27
    Drug · Prescription · Approval202300360
  • MFDS drugAmonosin-A inj.2022-12-28
    Drug · Prescription · Approval202204682
  • MFDS drugHutomega Soft Cap. 5/1000mg (Atorvastatin, Omega 3 acid ethyl esters 90)Revoked2022-07-08
    Drug · Prescription · Approval202202838
  • MFDS drugAzelopine Tab. 16mg (Azelnidipine)2022-06-13
    Drug · Prescription · Approval202202477
  • MFDS drugHuons Amino Injection 3%2022-06-10
    Drug · Prescription · Notification202202413
  • MFDS drugHULEVO Eye drops 1.5%2022-05-16
    Drug · Prescription · Approval202202084
  • MFDS drugAmoburofen premix Inj. (ibuprofen)2022-04-28
    Drug · Prescription · Approval202201732
  • MFDS drugHurion Inj. (Sugammadex sodium)2022-01-28
    Drug · Prescription · Approval202200511
  • MFDS drugAzelopine Tab. 8mg (Azelnidipine)2021-12-27
    Drug · Prescription · Approval202108116
  • MFDS drugDobeonce Tab. 500mg (Calcium Dobesilate hydrate)2021-10-06
    Drug · Prescription · Approval202106754
  • MFDS drugHudart Soft Cap. 0.5mg (Dutasteride)2021-08-20
    Drug · Prescription · Approval202106074
  • MFDS drugLinaD4 Duo Tab. 2.5/500mg (Linagliptin, Metformin)2021-08-12
    Drug · Prescription · Approval202105928
  • MFDS drugHUDIANCE Tab. 25mg2021-07-16
    Drug · Prescription · Approval202105424
  • MFDS drugHUDIANCE Tab. 10mg2021-07-16
    Drug · Prescription · Approval202105425
  • MFDS drugPelroen Tab. (Pelubiprofen (micronized))2021-05-24
    Drug · Prescription · Approval202104060
  • MFDS drugHuglia Tablet 50 mg2021-03-17
    Drug · Prescription · Approval202102407

Showing the 80 most recent of 467 records.

Clinical trials

data.go.kr

141 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 96 · Phase 1 33 · Phase 3 7 · Phase 2 3 · Phase 1/2a 1)

  • Phase 1HUC2A-7522026-08-04

    2 trial sites

  • Phase 1HUC2-7442026-07-24

    2 trial sites

  • BioequivalenceHUC3-7172026-07-07

    2 trial sites

  • Phase 1HUC2-6762026-06-16

    2 trial sites

  • BioequivalenceHUC3-6712026-04-27

    2 trial sites

  • Phase 2HUC1-3942026-03-11

    10 trial sites

  • Phase 1HUC2-6762025-12-16

    2 trial sites

  • BioequivalenceHUC3-6462025-12-01

    2 trial sites

  • Phase 1HUC2-5882025-11-28

    2 trial sites

  • Phase 1HUC3-6602025-11-28

    2 trial sites

  • Phase 1HUC2-5882025-11-27

    2 trial sites

  • Phase 1HUC3-6602025-11-27

    2 trial sites

Show 68 more
  • BioequivalenceHUC3-5312025-10-27

    2 trial sites

  • BioequivalenceHUC3-5312025-10-27

    2 trial sites

  • BioequivalenceHUC3-6232025-07-18

    2 trial sites

  • BioequivalenceHUC3-6392025-06-02

    2 trial sites

  • BioequivalenceHUC3-6522025-05-26

    2 trial sites

  • Phase 3HUC3-6372025-04-22

    20 trial sites

  • BioequivalenceHUC3-5622025-01-10

    2 trial sites

  • BioequivalenceHUC3-5562024-12-31

    2 trial sites

  • BioequivalenceHUC3-5722024-11-01

    2 trial sites

  • BioequivalenceHUC3-5392024-10-14

    2 trial sites

  • BioequivalenceHUC3-5782024-09-11

    1 trial site

  • Phase 1HUC2-3642024-09-04

    1 trial site

  • BioequivalenceHUC3-5332024-05-28

    2 trial sites

  • BioequivalenceHUC3-5372024-05-22

    1 trial site

  • BioequivalenceHUC3-5332024-05-07

    2 trial sites

  • Phase 1HUC3-4312024-03-26

    1 trial site

  • Phase 1HUC2-5652024-02-19

    1 trial site

  • Phase 1HUC1-3942024-01-05

    1 trial site

  • Phase 1HUC2-3442024-01-02

    1 trial site

  • Phase 1HUC2-3442024-01-02

    1 trial site

  • BioequivalenceHUC3-5122023-11-03

    2 trial sites

  • Phase 3카이닉스3점안액(히알루론산나트륨)(1회용)2023-10-31

    10 trial sites

  • BioequivalenceHUC3-1392023-08-28

    2 trial sites

  • Phase 1HUC3-4312023-05-22

    1 trial site

  • BioequivalenceHUC3-5132023-04-04

    2 trial sites

  • BioequivalenceHUC3-0402023-04-04

    2 trial sites

  • BioequivalenceHUC3-2832023-03-10

    2 trial sites

  • Phase 1HUC2-3442023-03-08

    1 trial site

  • BioequivalenceHUC3-3372023-01-09

    2 trial sites

  • BioequivalenceHUC3-3372023-01-09

    2 trial sites

  • Phase 3HU0072022-11-30

    10 trial sites

  • BioequivalenceHUC3-3302022-11-08

    2 trial sites

  • Phase 1HUC2-3442022-10-27

    1 trial site

  • BioequivalenceHUC3-2972022-09-29

    2 trial sites

  • BioequivalenceHUC3-2972022-09-29

    2 trial sites

  • Phase 1HUC2-3642022-07-14

    1 trial site

  • Phase 1HUC3-4312022-06-21

    1 trial site

  • Phase 1HUC3-4432022-06-21

    1 trial site

  • BioequivalenceHUC3-3502022-05-31

    2 trial sites

  • Phase 1HUC3-3422022-05-10

    1 trial site

  • BioequivalenceHUC3-0662022-04-11

    2 trial sites

  • BioequivalenceHUC3-3832022-04-07

    2 trial sites

  • Phase 1HUC2-3962022-04-01

    1 trial site

  • Phase 1HUC2-3962022-04-01

    1 trial site

  • BioequivalenceHUC3-1392022-01-14

    2 trial sites

  • BioequivalenceHUC3-4302022-01-14

    2 trial sites

  • BioequivalenceHUC3-3122021-12-01

    2 trial sites

  • BioequivalenceHUC3-3372021-12-01

    2 trial sites

  • BioequivalenceHUC3-3612021-11-17

    2 trial sites

  • BioequivalenceHUC3-3572021-10-20

    2 trial sites

  • BioequivalenceHUC3-3012021-09-10

    2 trial sites

  • BioequivalenceHUC3-4132021-09-09

    2 trial sites

  • BioequivalenceHUC3-3782021-08-11

    2 trial sites

  • BioequivalenceHUC3-3782021-08-10

    2 trial sites

  • BioequivalenceHUC3-3772021-06-16

    2 trial sites

  • BioequivalenceHUC3-3772021-06-14

    2 trial sites

  • Phase 1HUC2-3962021-06-14

    1 trial site

  • BioequivalenceHUC3-3062021-05-25

    2 trial sites

  • BioequivalenceHUC3-3762021-05-12

    2 trial sites

  • BioequivalenceHUC3-3752021-05-12

    2 trial sites

  • BioequivalenceHUC3-3762021-05-12

    2 trial sites

  • BioequivalenceHUC3-3512021-04-07

    2 trial sites

  • BioequivalenceHUC3-3722021-02-05

    2 trial sites

  • BioequivalenceHUC3-3712021-02-05

    2 trial sites

  • BioequivalenceHUC3-3742021-01-15

    2 trial sites

  • BioequivalenceHUC3-3502021-01-11

    2 trial sites

  • BioequivalenceHUC3-3312020-12-17

    2 trial sites

  • Phase 1/2aHU024 점안액2020-10-29

    1 trial site

Showing the 80 most recent of 141 records.

AI reads

MAA server logs · IP-verified
1
Read to answer a question

Someone asked an AI a question, and it fetched this page live to answer.

0
Crawled for indexing

Collected for later use. Not a signal of interest.

1answer
index 0
Last 7 days
1answer
index 0
Last 30 days
1answer
index 0
All time
  • OpenAIChatGPT-Useranswer1

Measured since Aug 26, 2026 · 1 AI engines · last read Aug 26, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.

Connect this index to your AI tool →

Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

CAREGEN CO.,LTD.2 shared

CAREGEN develops peptide-based cosmeceuticals sold in 130 countries and ophthalmic drug candidates CG-P5 and CG-T1.

Humedix Co., Ltd.2 shared

KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.

anymedi Inc.1 shared

Uses AI analysis of medical imaging to 3D-print patient-specific surgical guides, implants, and simulators.

Chong Kun Dang Pharmaceutical Corp.1 shared

Spun off and listed in 2013, Chong Kun Dang out-licensed its HDAC6 inhibitor CKD-510 to Novartis in a deal worth about KRW 1.7 trillion.

Daehan Nupharm Co.,Ltd.1 shared

KOSDAQ-listed pharmaceutical company producing a diverse, low-volume portfolio of metabolic disease drugs, wellness injections, and veterinary medicines.

DongKookPharmaceuticalCo.,Ltd.1 shared

KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.

Hanmi Pharm. Co., Ltd.1 shared

KOSPI-listed pharmaceutical company behind the combination drugs Amosartan (hypertension) and Rosuzet (dyslipidemia).

HANS BIOMED CORPORATION1 shared

KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.

Hironic Co.,Ltd1 shared

KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.

Hugel, Inc.1 shared

Hugel is a KOSDAQ-listed pharmaceutical/CDMO company making a botulinum toxin injectable and the hyaluronic acid filler The Chaeum.

Medy-Tox Inc.1 shared

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

NUON CO., LTD.1 shared

KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition